Study identifier:D2287R00155
ClinicalTrials.gov identifier:NCT05169619
EudraCT identifier:N/A
CTIS identifier:N/A
Epi-Asthma: Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal
asthma
N/A
Yes
-
All
842
Observational
18 Years - n/a
Allocation: Randomized
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Mar 2025 by AstraZeneca
AstraZeneca
Faculdade de Medicina da Universidade do Porto - CINTESIS, Universidade do Minho - ICVS
This study aims to determine the prevalence of Asthma, Difficult-to-Treat and Severe Asthma in Portugal, and characterize patients to better understand their disease characteristics, treatment profile and health care resource use to improve clinical management of the disease.
Data on the epidemiology of asthma in Portugal were mainly grounded in studies using questionnaires and covering limited age groups. Studies assessing the prevalence of asthma diagnosis and of its sub-groups with more accurate methods are therefore needed This study aims to determine the prevalence of asthma, difficult-to-treat and severe asthma in Portugal, and to characterize patients to better understand their disease characteristics, treatment profile and health care resource use to improve clinical management of the disease. We will conduct a population-based nationwide study with a multicentre stepwise approach, enrolling 7500 adult subjects, randomly selected, from the Portuguese National Health Service patients’ database of 38 primary care centres: STAGE 0 – Phone call invitation and enrolment of participants STAGE 1 – Telephone interview survey to assess respiratory symptoms. STAGE 2 – Clinical assessment, diagnostic confirmation, and patient characterization STAGE 3 – Characterization of asthma patients (sub-group) and characterization of difficult- to-treat asthma & severe asthma patients after 3 months follow up period.
Location
Location
Pinhal Novo, Portugal, Portugal, 2955-050
Location
Cascais, Portugal, Portugal, 2750-642
Location
Queluz, Portugal, Portugal, 2745-862
Location
Mafra, Portugal, Portugal, 2640-465
Location
Quinta do Conde, Portugal, Portugal, 2975-326
Location
Vila Nova da Barquinha, Portugal, Portugal, 2260-400
Location
Tomar, Portugal, Portugal, 2300-469
Location
Rio de Mouro, Portugal, Portugal, 2635-364
Arms | Assigned Interventions |
---|
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.